期刊
BRAIN CIRCULATION
卷 5, 期 1, 页码 8-11出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/bc.bc_36_18
关键词
Stroke; thrombectomy; thrombolysis; tissue plasminogen activator
资金
- NIH [R01NS104349, SC3GM122593]
Stroke is a leading cause of death and long-term disabilities. Despite decades of extensive efforts in search of brain injury mechanisms and therapeutic interventions, pharmacological treatment is limited to the use of thrombolytic agent tissue plasminogen activator, which has limited therapeutic time window and potential side effect of intracranial hemorrhage. Over the past few years, endovascular thrombectomy with stent-retriever devices combined with advanced imaging modalities has transformed the standard of stroke care, offering an opportunity to improve the outcome in selected patients as late as 24 h after the onset of stroke. This mini-review summarizes the advancement in the treatment of ischemic stroke, from thrombolysis to thrombectomy and remaining challenges in the field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据